Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment
Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment
Recruiting · NCT04875611 · Registry updated 2025-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment | Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, malignant tumor of nasopharynx, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 2 | 2025-04-24 | NCT04875611 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| KCRI | 14 |
| Maria Sklodowska-Curie National Research Institute of Oncology | 28 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.